Valent BioSciences Launches New Biostimulant Operating Unit

FOR IMMEDIATE RELEASE

LIBERTYVILLE, Illinois, October 12, 2022 – Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1. The new operating unit was established in February 2022 and it is now fully operational, enabling the organization to serve the entire U.S market. This transition marks a major change in the go-to-market strategy for Valent BioSciences, as the company begins selling biostimulant products directly to U.S. channel partners.

The new biostimulant business team and salesforce are focused on discovering, developing, and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability.

“As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,” said Salman Mir, Executive Vice President and Chief Operating Officer at Valent BioSciences. “Biostimulant products, including our AMF technologies, also support the mission of our parent company, Sumitomo Chemical Co., Ltd., for achieving carbon neutrality by 2050, as well as its global goal of attaining carbon neutrality for society as a whole.”

The core Valent BioSciences biostimulant products are being marketed under the SymvadoTM and ProliantTM brand names. The team is focused on achieving customer success with biostimulants and will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market.

“We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,” said Dave Schumacher, Vice President of Commercial Operations for Valent BioSciences.

The new biostimulants business at Valent BioSciences includes numerous technical experts who are available to help retailers and growers navigate this complex market segment.

“We have more than 60 years of broad biorational crop enhancement expertise, and this launch incorporates the next generation of tools to help our customers succeed,” said Mir. “We are in an excellent position to lead the biostimulants industry as it transitions to science-driven biostimulant products that positively impact the bottom line.”

For more information about Valent BioSciences biostimulant products, please call 877-696-4204 or email biostimulants@valentbiosciences.com.

###

About Valent BioSciences LLC

Headquartered in Libertyville, Illinois, Valent BioSciences is a subsidiary of Tokyo-based Sumitomo Chemical Co., Ltd., and is the worldwide leader in the development, manufacturing, and commercialization of biorational products, with sales in 95 countries around the world. Valent BioSciences is an ISO 9001 Certified Company. For additional information, visit the company’s website at www.valentbiosciences.com.

Media Contact:

John Mandel
Valent BioSciences LLC
+1-847-968-4728
Email: john.mandel@valentbiosciences.com

Download Press Release

Share:

Related News

Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forest health, has announced that the company began selling biostimulant products directly to its U.S. customer base on October 1.
Sumitomo Chemical Co., Ltd. (SCC), parent company of Valent U.S.A. and Valent Biosciences, today announced a new entity called Valent North America that will provide enterprise business services across the Valent group of companies. 
Valent BioSciences LLC, the global biorational products leader in agriculture, public health, and forestry, has announced the promotion of Salman Mir to Executive Vice President and Chief Operating Officer. He will continue reporting to Ted Melnik, Valent BioSciences’ President and Chief Executive Officer.
To promote its industry leadership in biorational and biostimulant product innovation, Valent BioSciences LLC has announced significant investments at several of its key research and development facilities.
Valent BioSciences LLC announced today that it has approved a major expansion of its biorational manufacturing facility in Osage, Iowa, which will meet increasing demand for its biorational products and the introduction of new products requiring more capacity.
The U.S. Environmental Protection Agency recently granted Valent BioSciences LLC an Experimental Use Permit (EUP) to perform further field studies of VBC-60748, a new mosquito space spray targeting pyrethroid-resistant adult mosquitoes.